DaVita Inc. 2nd Quarter 2017 Results
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2017. Net income attributable to DaVita Inc. for the quarter ended June 30, 2017 was $127 million, or $0.65 per…
Uncategorized
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
DaVita Medical Group Acquires Respected Physician Practices in the Orlando Area
DaVita Medical Group, a division of DaVita Inc. (NYSE: DVA) and a leading independent medical group in the United States, today announced the acquisition of Dr. Rahn Shaw’s practices, Park Avenue…
DaVita Inc. Schedules 2nd Quarter 2017 Investor Conference Call
DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading global provider of kidney care services, today announced that it will hold its quarterly conference call to discuss…
DaVita Medical Group Recognized for Excellence in Coordinated Care
DaVita Medical Group, a division of DaVita Inc. (NYSE: DVA) and a leading independent medical group in the United States, today announced that it received top awards from CAPG, the nation’s…
Dr. David Mahoney Named Chief Medical Officer of Lifeline Vascular Access
Lifeline Vascular Access®, a subsidiary of DaVita Inc. (NYSE: DVA) and leading management company that serves providers of vascular care for patients with a variety of chronic conditions,…